Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hopfer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer|January 15, 1983
Aspergillus epiglottitisR Bolivar, L G Gomez, M Luna, et al.
Biochimica Et Biophysica Acta|March 14, 1984
Liposomal amphotericin B is toxic to fungal cells but not to mammalian cellsR Mehta, G Lopez-Berestein, R Hopfer, et al.
Medicine|March 1, 1988
The emerging role of Fusarium infections in patients with cancerE Anaissie, H Kantarjian, J Ro, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infectionsR L Juliano, G Lopez-Berestein, R Hopfer, et al.
Cancer Drug Delivery|January 1, 1983
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasisG Lopez-Berestein, R Mehta, R Hopfer, et al.
The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Airways delivery of rifampicin microparticles for the treatment of tuberculosisS Suarez, P O'Hara, M Kazantseva, et al.
Pharmaceutical Research|October 31, 2001
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease modelS Suarez, P O'Hara, M Kazantseva, et al.
Reviews of Infectious Diseases|May 1, 1989
New spectrum of fungal infections in patients with cancerE Anaissie, G P Bodey, H Kantarjian, et al.
The Journal of Infectious Diseases|April 1, 1985
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary studyG Lopez-Berestein, V Fainstein, R Hopfer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|January 15, 1983
Aspergillus epiglottitisR Bolivar, L G Gomez, M Luna, et al.
Biochimica Et Biophysica Acta|March 14, 1984
Liposomal amphotericin B is toxic to fungal cells but not to mammalian cellsR Mehta, G Lopez-Berestein, R Hopfer, et al.
Medicine|March 1, 1988
The emerging role of Fusarium infections in patients with cancerE Anaissie, H Kantarjian, J Ro, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infectionsR L Juliano, G Lopez-Berestein, R Hopfer, et al.
Cancer Drug Delivery|January 1, 1983
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasisG Lopez-Berestein, R Mehta, R Hopfer, et al.
The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Airways delivery of rifampicin microparticles for the treatment of tuberculosisS Suarez, P O'Hara, M Kazantseva, et al.
Pharmaceutical Research|October 31, 2001
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease modelS Suarez, P O'Hara, M Kazantseva, et al.
Reviews of Infectious Diseases|May 1, 1989
New spectrum of fungal infections in patients with cancerE Anaissie, G P Bodey, H Kantarjian, et al.
The Journal of Infectious Diseases|April 1, 1985
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary studyG Lopez-Berestein, V Fainstein, R Hopfer, et al.
Pageof 1